Cargando…
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
Background: Brain metastases are associated with poor survival. Molecular genetic testing informs on targeted therapy and survival. The purpose of this study was to perform a MR imaging-based radiomic analysis of brain metastases from non-small cell lung cancer (NSCLC) to identify radiomic features...
Autores principales: | Chen, Bihong T., Jin, Taihao, Ye, Ningrong, Mambetsariev, Isa, Wang, Tao, Wong, Chi Wah, Chen, Zikuan, Rockne, Russell C., Colen, Rivka R., Holodny, Andrei I., Sampath, Sagus, Salgia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973105/ https://www.ncbi.nlm.nih.gov/pubmed/33747933 http://dx.doi.org/10.3389/fonc.2021.621088 |
Ejemplares similares
-
Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach
por: Chen, Bihong T., et al.
Publicado: (2020) -
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status
por: Chen, Bihong T., et al.
Publicado: (2023) -
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report
por: Roth, Katherine G., et al.
Publicado: (2020) -
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
por: Won, Brian, et al.
Publicado: (2016) -
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
por: Chen, Bihong T., et al.
Publicado: (2018)